These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 12583543

  • 1. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P, Metallidis S, Katikaridou E, Chatzidimitriou M, Kollaras P, Tsona A, Koumentaki E, Tourkantonis A.
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [Abstract] [Full Text] [Related]

  • 2. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    Garcia R, Raad I.
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):933-6. PubMed ID: 9031876
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    Hamel A, Caillon J, Jacqueline C, Batard E, Potel G.
    Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H, Giamarellos-Bourboulis EJ, Grecka P, Chryssouli Z, Giamarellou H.
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [Abstract] [Full Text] [Related]

  • 5. Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey.
    Azap OK, Arslan H, Timurkaynak F, Yapar G, Oruç E, Gagir U.
    Clin Microbiol Infect; 2005 Jul; 11(7):582-4. PubMed ID: 15966979
    [Abstract] [Full Text] [Related]

  • 6. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M, Yazgi H, Aktaş E, Ayyildiz A, Parlak M.
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
    Abb J.
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):319-21. PubMed ID: 12151194
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B, Merckoll P, Melby KK.
    Scand J Infect Dis; 2007 Aug; 39(11-12):1059-62. PubMed ID: 17852934
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S, Chatzidimitriou M, Nikolaidis P, Tsona A, Bisiklis A, Kollaras P, Tsiakiri E, Koumentaki E, Alexiou-Daniel S.
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [Abstract] [Full Text] [Related]

  • 11. A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.
    Low DE, Nadler HL.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():53-8. PubMed ID: 9511063
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus.
    Ozmen Capin BB, Tekeli A, Karahan ZC.
    Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L, Nicola L, De Vecchi E.
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [Abstract] [Full Text] [Related]

  • 17. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P, Lemaire S, Denis O, Tulkens PM, Van Bambeke F, Glupczynski Y.
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci.
    Betriu C, Redondo M, Boloix A, Gómez M, Culebras E, Picazo JJ.
    J Antimicrob Chemother; 2001 Dec; 48(6):911-3. PubMed ID: 11733478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.